Vision Clear: Ophthalmic Eye Drops Market Projected to Surpass US$ 24.53 Billion by 2033, Sustaining a Robust CAGR of 4.2%

The worldwide Ophthalmic Eye Drops Market sparkles brilliantly, enlightening the tremendous scene of the medical services industry with its gigantic potential. This market is ready to accomplish a surprising valuation of US$ 16.21 billion out of 2023. Future Market Bits of Knowledge (FMI) imagines a future where the market arrives at new levels, outperforming US$ 24.53 billion by 2033. This ascent paints a striking embroidery of progress, moved by a consistent CAGR of 4.2%.

The National Ambulatory Medical Care Survey indicated that Americans made more than 4 million visits to ambulatory physicians for bacterial conjunctivitis in 2005. Approximately 70% of patients with acute conjunctivitis present to primary and urgent care providers, which accounts for 1% of all primary care office visits. Adenoviruses account for 65 to 90% of cases of viral conjunctivitis.

The soaring cases of eye infections have been driving ophthalmic eye drops sales. While the report presents positive outlook for growth, ongoing restrictions amid COVID-19 outbreak might hamper sales.

Get your hands on a visually captivating sample report featuring related graphs and charts. @  https://www.futuremarketinsights.com/reports/sample/rep-gb-13140

New eye drop product launches, branded as well as generic, are expected to be hampered in the short term due to disruptions in the supply chain, delayed pipeline research and development and shift in the priority of leading healthcare companies to COVID-19 vaccine and treatment developments.

According to the report, institutional sales of ophthalmic eye drops will rise considerably in the coming years. It will account for over half of ophthalmic eye drops sold through the forecast period.

“Increasing prevalence of eye infections, technological advancements, and high risk of infections from increasing use of contact lens are expected to boost the growth of the ophthalmic eye drops market.” says the FMI Analyst

Key Takeaways from Ophthalmic Eye Drops Market Study

  • Ophthalmic eye drops market will expand consistently to surpass a valuation of US$ 15 Bn by 2021
  • The U.S. holds over 92.1% share of the North American market, but Canada is projected to expand faster at around 4.0% CAGR
  • Rising cases of eye infection will drive sales in the U.K., enabling it register 3.9% y-o-y growth in 2021
  • Rising willingness to spend on advanced eye care will drive sales in Germany and France
  • Expansion of the healthcare sector will emerge as chief growth driver in China and Japan. Both countries will exhibit high demand for dilation drops

Due to their increasingly active lifestyle and desire for better aesthetics, many people are shifting to contact lenses. However, many ocular infections are associated with the use of contact lenses. Each year in the United States, approximately 1 million eye infections occur related primarily to keratitis, a fungal infection of the cornea, and contact lens infections account for estimated direct costs of $175 million. In addition, 40.9 million U.S. adults wear contact lenses, and 99% of 4,269 contact-lens wearers were reported at least one contact lens – related hygiene behavior associated with an increased risk for eye infection or inflammation. Nearly a million eye infections requiring a trip to the doctor happen each year, many of them related to contact lens use.

Talk with our analyst and Understanding the study’s assumptions @  https://www.futuremarketinsights.com/ask-question/rep-gb-13140

Who is Winning?

The top players are focusing on increasing acquisitions at the regional level. Acquisitions empower the company with products and increase the company’s portfolio. The company acquires other players to possess well-established products and solutions that are expected to become a good revenue source for the acquirer. Acquisitions also enable the company to enter new emerging markets as well as enhance their presence in existing markets. Furthermore, key market players such as Novartis and Gerresheimer AG are focusing on the expansion of their market reach in different regions. For example-

  • In November 2020, Gerresheimer Regensburg announced that it is expanding its production area in Germany. The company has planned the expansion of its production capacity in small batch production, as a result of increasing development projects for pharmaceutical and medical technology products.
  • In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, strengthening its position in the world’s third largest generics market.

Some of the key market players covered by FMI include Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., and Amcor Plc.

Heighten Your Value with Savings on securing this Report. @ https://www.futuremarketinsights.com/checkout/13140

Ophthalmic Eye Drops Market by CategoryDrug Class

  • Anesthetic Drops
  • Dilation Drops
  • Glaucoma Drops
  • Steroid Drops
  • Antibiotic Drops
  • Others (Antihistamine, Lubricants Tear Drops)

Indication

  • Dry Eye
  • Eye Allergy
  • Glaucoma
  • Eye Infection
  • Retinal Disorders
    • Macular Degeneration
    • Diabetic Retinopathy
    • Others
  • Uveitis
  • Others

Drug Formulation

  • With Preservative
  • Preservative Free

Container Type

  • Single Dose Container
  • Multiple-Dose Container

Distribution Channel

  • Institutional Sales
    • Hospitals
    • Community Clinics
    • Ophthalmic Clinics
    •  Public Health Agencies
    • Veterinary Hospitals & Clinics
  • Retail Sales
    • Retail Pharmacies
    •  Drug Stores

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.

Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.

Sepsis Diagnostics MarketThe global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogsYouTube

Leave a comment

Your email address will not be published. Required fields are marked *